AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CEFADROXIL 500 Mg ;

10 registrations across 1 African market— 10 active

Markets with CEFADROXIL 500 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Ronicefada
Powder for Oral Suspension
🇪🇬EgyptAVERROES PHARMA for pharmaceutical industriesactive
Megadroxil
Hard Gelatin Capsules
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Curisafe 500 mg/ 5 ml
Powder for Oral Suspension
🇪🇬EgyptPharco B Internationalactive
Curisafe 500 mg
Hard Gelatin Capsules
🇪🇬EgyptPharco B Internationalactive
DURICEF 500 mg
Hard Gelatin Capsules
🇪🇬EgyptSMITHKLINE BEECHAM-EGYPTactive
Ronicefada
Powder for Oral Suspension
🇪🇬EgyptAVERROES PHARMA for pharmaceutical industriesactive
Megadroxil
Hard Gelatin Capsules
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Curisafe 500 mg/ 5 ml
Powder for Oral Suspension
🇪🇬EgyptPharco B Internationalactive
Curisafe 500 mg
Hard Gelatin Capsules
🇪🇬EgyptPharco B Internationalactive
DURICEF 500 mg
Hard Gelatin Capsules
🇪🇬EgyptSMITHKLINE BEECHAM-EGYPTactive

CEFADROXIL 500 Mg ; in Africa — Regulatory Overview

CEFADROXIL 500 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.